Table 4 A detailed description of dataset labels and clinical predictors
Dataset name | Type of labels | Clinical predictors |
|---|---|---|
LIDC-IDRI | Malignancy diagnosis (patient-level and nodule-level) | - |
LNDb | Fleischner score | - |
NSCLC-Radiogenomics | Survival data, TNM status (for selected cases) | Age, weight, gender, ethnicity, smoking status, tumor histology, treatment (yes/no) |
NSCLC-Radiomics | Overall survival, TNM status | Age, gender, tumor histology |
LUAD-CT-Survival | Survival class (top quartile—long survival/lowest quartile—short survival) | - |
RIDER-Lung-CT | Not available—repeatability study | - |
BraTS-2021 | MGMT promoter methylation status | - |
UCSF-PDGM | MGMT promoter methylation status, IDH mutation status, overall survival | Age |
UPENN-GBM | Overall survival, MGMT promoter methylation status, IDH mutation status, progression score | Age, gender |
Meningioma-SEG-CLASS | Pathologic grade | Age, sex, tumor subtype, atypical features |
LGG-1p19qDeletion | 1p/19q deletion status | Tumor histology |
PI-CAI | Gleason score (csPCa vs. non-csPCa) | Age, PSA, PSAD, prostate volume |
Prostate-MRI-US-Biopsy | Gleason score (csPCa vs. non-csPCa) | - |
QIN-PROSTATE | Not available—repeatability study | - |
Head-Neck-Radiomics-HN1 | Overall survival, recurrence-free survival, time to local/locoregional/distant recurrence, TNM status, AJCC stage | Age, sex, HPV p16 status, pretreatment Hb concentration, detailed treatment |
HNSCC | Overall survival, recurrence-free survival, time to local/regional/locoregional/distant recurrence, TNM status, AJCC stage | Age, gender, smoking status, HPV status, detailed treatment |
Head-Neck-PET-CT | Overall survival, time to locoregional recurrence, time to distant metastasis, TNM status | Age, sex, HPV status, therapy type |
OPC-Radiomics | Overall survival, time to local/regional/distant failure, TNM status | Age, sex, ECOG performance status, smoking status, alcohol status, tumor histology |
QIN-HEADNECK | Overall survival with cause of death, recurrence-free survival with recurrence location, TNM status | Age, sex, weight, height, race, medical history, alcohol status, smoking status, treatment info |
Colorectal-Liver-Metastases | Overall survival, time to disease progression, time to liver disease progression | Age, sex, NASH score, total response (%), necrosis (%), fibrosis (%), mucin (%) |
HCC-TACE-Seg | Overall survival and time-to-progression, TNM status | Age, sex, smoking status, alcohol status, HBV/HCV status, medical history, pathology differentiation status, metastasis presence, vascular invasion, AFP level, CLIP score, detailed therapy, EASL, RECIST |
C4KC-KiTS | Overall survival, TNM status, ISUP grade | Age, gender, BMI, comorbidities, smoking status, alcohol status, tumor histology subtype, detailed treatment, eGFR preop and postop |
Soft-tissue-Sarcoma | Overall survival, disease-free survival (with recurrence/metastasis location) | Age, sex, tumor histology, treatment info |
WORC Desmoid | Binary (fibromatosis vs. sarcoma) | Age, sex |
WORC Liver | Binary (malignant vs. benign lesion) | Age, sex |
WORC CRLM | Binary (histological growth type) | Age, sex |
WORC Melanoma | Binary (BRAF mutated vs. BRAF wild) | Age, sex |
WORC Lipo | Binary (liposarcoma vs. lipoma) | Age, sex |
WORC GIST | Binary (GIST vs. non-GIST) | Age, sex |